ProQinase wishes to support participants of clinical trials by supplying services ranging from the design of the study protocol over methodological advice regarding sample processing and logistics to the timely quantification of soluble biomarkers. In addition ProQinase is in the position to call in experienced physicians that reconcile biomarker with clinical data. Using this special approach biomarker data generated during clinical trials can reach a much higher significance.

Clinical biomarker analysis is available for the following markers (serum or plasma):

¹EDTA-Plasma, X= preferred source; (X)= on request; X* = platelet poor plasma

¹EDTA-Plasma, X= preferred source; (X)= on request; X* = platelet poor plasma

Additional information about soluble biomarkers can be downloaded here (pdf file).

Please inquire for more information on our setups.

Please ask for our guidelines for collection and processing of serum- and EDTA-plasma samples for biomarker analysis.